Clinical Trial Update: DSP-0390 in Combination With Atezolizumab for Small Cell Lung Cancer [Phase 1]

View source ↗

Summary

Phase 1 study of DSP-0390 in combination with atezolizumab for small cell lung cancer; the trial is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)
• DSP-0390

Snippet

Sponsor: Washington University School of Medicine | Conditions: Small-cell Lung Cancer, Small Cell Lung Cancer Extensive Stage | Phase 1 | Status: NOT_YET_RECRUITING